Use of non-homogeneous Poisson process for the analysis of new cases, deaths, and recoveries of COVID-19 patients: A case study of Kuwait

被引:0
|
作者
Al-Dousari, Ahmad [1 ]
Ellahi, Asad [2 ,3 ]
Hussain, Ijaz [3 ]
机构
[1] Kuwait Univ, Dept Geog, Kuwait, Kuwait
[2] Natl Univ Med Sci, Wah Med Coll, Dept Community Med, Rawalpindi, Pakistan
[3] Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan
关键词
Bayesian analysis; Non-homogeneous Poisson process; SARS-CoV-2; Markov chain; COVID-19; pandemic; Kuwait;
D O I
10.1016/jaksus.2021.101614
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The coronavirus disease spread out rapidly in China and then in the whole world. Kuwait is one of those countries which are positively affected by this pandemic. Objective: The current study aims to provide an appropriate and novel framework for the analysis of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infected patient & rsquo;s counts and rate of change in these counts with respect to time. Therefore, we considered the number of SARS-CoV-2 patients, i.e., confirmed cases, deaths, and recover-ies for Kuwait, ranging from the 24th of February 2020 to the 25th of August 2020. Method: Here, we used the Markov Chain Monte Carlo (MCMC) simulation methods for the data analysis of SARS-CoV-2 to develop the Bayesian analysis of the Non-Homogeneous Poisson Process (NHPP). For this purpose, we used the two unique models of NHPP: the linear intensity function and the power law process. The dis-crimination methods are also discussed to select a better model for daily basis data of confirmed cases, deaths, and recoveries of SARS-CoV-2 patients. The appropriate model is selected based on the Deviance Information Criteria (DIC). Results: The value of DIC indicates that the power-law process performs better than the linear intensity functions for estimating and presenting all the study variables. The current study explored the usefulness and significance of the proposed research framework to analyze the SARS-CoV-2 new confirmed cases, recoveries, and deaths in a specific area. Conclusion: The findings of the study will be helpful for the health organizations or authorities to develop the approaches based on the current resources and situations due to the pandemic. The provided framework could be beneficial in analyzing the second and third layers of COVID-19 in the area. The analysis of the counts for each study variable and for each variable a comparative analysis of all the three layers is the aim of our future study. (c) 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:11
相关论文
共 50 条
  • [31] New Strategy of Home-Based Exercise during Pandemic COVID-19 in Breast Cancer Patients: A Case Study
    Grazioli, Elisa
    Cerulli, Claudia
    Dimauro, Ivan
    Moretti, Elisa
    Murri, Arianna
    Parisi, Attilio
    SUSTAINABILITY, 2020, 12 (17)
  • [32] Epidemiology and Mycology of Candidaemia in non-oncological medical intensive care unit patients in a tertiary center in the United States: Overall analysis and comparison between non-COVID-19 and COVID-19 cases
    Macauley, Precious
    Epelbaum, Oleg
    MYCOSES, 2021, 64 (06) : 634 - 640
  • [33] Time series analysis of the incidence of acute upper respiratory tract infections, COVID-19 and the use of antibiotics in Finland during the COVID-19 epidemic: a cohort study of 833 444 patients
    Niemenoja, Oskar
    Taalas, Ara
    Taimela, Simo
    Bono, Petri
    Huovinen, Pentti
    Riihijarvi, Sari
    BMJ OPEN, 2022, 12 (01):
  • [34] Acceleration of Telemedicine Use for Chronic Neurological Disease Patients during COVID-19 Pandemic in Yogyakarta, Indonesia: A Case Series Study
    Pinzon, Rizaldy
    Paramitha, Dessy
    Wijaya, Vincent Ongko
    KESMAS-NATIONAL PUBLIC HEALTH JOURNAL, 2020, 15 (02): : 28 - 31
  • [35] Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study
    Viceconte, Giulio
    Buonomo, Antonio Riccardo
    D'Agostino, Alessia
    Foggia, Maria
    Di Fusco, Antonio
    Pinchera, Biagio
    Scotto, Riccardo
    Iacovazzo, Carmine
    Fanasca, Luca
    Messina, Gaetana
    Cacciatore, Francesco
    Salvatore, Paola
    Gentile, Ivan
    JOURNAL OF FUNGI, 2023, 9 (08)
  • [36] Assessing efficacy of antiviral therapy for COVID-19 patients: A case study on remdesivir with bayesian synthesis design and multistate analysis
    Liao, Sih-Han
    Hung, Chien-Ching
    Chen, Chiung-Nien
    Yen, Jui-Yi
    Hsu, Chen-Yang
    Yen, Amy Ming-Fang
    Chen, Chi-Ling
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 : S77 - S85
  • [37] Off-label drug use during the COVID-19 pandemic in Africa: topic modelling and sentiment analysis of ivermectin in South Africa and Nigeria as a case study
    Nia, Z. Movahedi
    Bragazzi, N. L.
    Ahamadi, A.
    Asgary, A.
    Mellado, B.
    Orbinski, J.
    Seyyed-Kalantari, L.
    Woldegerima, W. A.
    Wu, J.
    Kong, J. D.
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2023, 20 (206)
  • [38] Microbial Landscape and Antibiotic-Susceptibility Profiles of Microorganisms in Patients with Bacterial Pneumonia: A Comparative Cross-Sectional Study of COVID-19 and Non-COVID-19 Cases in Aktobe, Kazakhstan
    Ablakimova, Nurgul
    Mussina, Aigul Z.
    Smagulova, Gaziza A.
    Rachina, Svetlana
    Kurmangazin, Meirambek S.
    Balapasheva, Aigerim
    Karimoldayeva, Dinara
    Zare, Afshin
    Mahdipour, Mahdi
    Rahmanifar, Farhad
    ANTIBIOTICS-BASEL, 2023, 12 (08):
  • [39] Analysis of prognostic factors in COVID-19 hospitalized patients: an Italian single-center case-control study
    Concistre, A.
    Petramala, L.
    Pugliano, C. L.
    Celi, M.
    Vinci, F.
    Assanto, E.
    Barchetta, I.
    Perrone, E. P.
    Rella, S.
    Iannazzo, F.
    Angheloni, A.
    Coraggio, L.
    Di Rienzo, F.
    Maggi, D.
    Circosta, F.
    Galardo, G.
    Muscaritoli, M.
    Letizia, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (03) : 1207 - 1221
  • [40] New Product Estimators for Population Mean Under Unequal Probability Sampling with Missing Data: A Case Study on the Number of New COVID-19 Patients
    Ponkaew, Chugiat
    Lawson, Nuanpan
    THAILAND STATISTICIAN, 2024, 22 (03): : 634 - 656